AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20179259 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 1 mg once daily
Number of subjects: 100
Study 20179259 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg once daily
Number of subjects: 100
Study 17688921 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence in situ hybridization (FISH)
Number of subjects: 166
Study 17688921 — intervention group
Group type: EXPERIMENTAL
Intervention: UBC-ELISA
Number of subjects: 166
Study 17688921 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytology
Number of subjects: 166
Study 17688921 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytology and FISH
Number of subjects: 166
Study 17688921 — intervention group
Group type: COMPARATOR
Intervention: False-positive results of FISH
Number of subjects: 166
Study 17688921 — intervention group
Group type: COMPARATOR
Intervention: False-positive results of UBC
Number of subjects: 166
Study 17688921 — intervention group
Group type: COMPARATOR
Intervention: False-positive results of cytology
Number of subjects: 166
Study 15675981 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO therapy
Number of subjects: 30
Study 15675981 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rHuEPO therapy)
Number of subjects: 30
Study 12002961 — intervention group
Group type: EXPERIMENTAL
Intervention: Affirmative action plans with special training opportunities for minorities
Number of subjects: 1173
Study 12002961 — intervention group
Group type: EXPERIMENTAL
Intervention: Affirmative action plans (various contents)
Number of subjects: 1173
Study 10197560 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet only (4.19-5.44 MJ/d)
Number of subjects: 98
Study 10197560 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise only (five, 45-min sessions/wk at 78.5 +/- 0.5% of maximum heart rate)
Number of subjects: 98
Study 10197560 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercise and diet
Number of subjects: 98
Study 10197560 — intervention group
Group type: COMPARATOR
Intervention: Control (no diet or exercise)
Number of subjects: 98
Study 8869020 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hirudin (CGP 39,393/TMREVASC)
Number of subjects: 0
Study 8869020 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study 2266990 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazindol (3 mg/d)
Number of subjects: 83
Study 2266990 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazindol
Number of subjects: 83
Study 2266990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 6106828 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphinpyrazone (SPZ) 200 mg orally
Number of subjects: 15
Study 6106828 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 31095562 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced pain
Number of subjects: 0
Study 31095562 — intervention group
Group type: COMPARATOR
Intervention: Active placebo
Number of subjects: 0
Study 31095562 — intervention group
Group type: COMPARATOR
Intervention: Neutral
Number of subjects: 0
Study 28317828 — intervention group
Group type: EXPERIMENTAL
Intervention: magnetic therapy for 5 min №10 in maxillary and mandibular areas
Number of subjects: 60
Study 28317828 — intervention group
Group type: COMPARATOR
Intervention: impulse carbonate irrigation for 12 min №10
Number of subjects: 60
Study 25544113 — intervention group
Group type: COMPARATOR
Intervention: Iron alone (5mg as FeSO4)
Number of subjects: 28
Study 25544113 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron with phytic acid (10mg)
Number of subjects: 28
Study 25544113 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron with tannic acid (100mg)
Number of subjects: 28
Study 25544113 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron with citrus pectin (250mg)
Number of subjects: 28
Study 25544113 — intervention group
Group type: COMPARATOR
Intervention: Iron alone with calcium (800mg CaCl2)
Number of subjects: 28
Study 25544113 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron with phytic acid and calcium
Number of subjects: 28
Study 25544113 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron with tannic acid and calcium
Number of subjects: 28
Study 25544113 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron with citrus pectin and calcium
Number of subjects: 28
Study 23685999 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy surgery
Number of subjects: 122
Study 21453706 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS-treated samples
Number of subjects: 0
Study 21453706 — intervention group
Group type: COMPARATOR
Intervention: Untreated samples
Number of subjects: 0
Study 19837362 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV information presentation
Number of subjects: 0
Study 16330466 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (ramipril 5 mg/day + candesartan 8 mg/day)
Number of subjects: 21
Study 16330466 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril alone (10 mg/day)
Number of subjects: 21
Study 16330466 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan alone (16 mg/day)
Number of subjects: 21
Study 16330466 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline urinary TGF-beta1 level)
Number of subjects: 21
Study 15469418 — intervention group
Group type: EXPERIMENTAL
Intervention: N4311S polymorphism
Number of subjects: 1442
Study 15469418 — intervention group
Group type: EXPERIMENTAL
Intervention: E4154K (EcoRI) polymorphism
Number of subjects: 1442
Study 15469418 — intervention group
Group type: EXPERIMENTAL
Intervention: T2488T (XbaI) polymorphism
Number of subjects: 1442
Study 10955239 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazopran (CZOP)
Number of subjects: 80
Study 10955239 — intervention group
Group type: COMPARATOR
Intervention: Cefpirome (CPR)
Number of subjects: 80
Study 9323778 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (structured dialogue focusing on concepts of pain)
Number of subjects: 92
Study 8225636 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg b.i.d. for 5 days
Number of subjects: 221
Study 8225636 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg b.i.d. for 10 days
Number of subjects: 221
Study 8225636 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 221
Study 3081928 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 0.3 mg/kg
Number of subjects: 13
Study 3081928 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam 1.2 mg/kg
Number of subjects: 13
Study 3081928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 30230257 — intervention group
Group type: EXPERIMENTAL
Intervention: Old drug product (DP)
Number of subjects: 48
Study 30230257 — intervention group
Group type: EXPERIMENTAL
Intervention: New drug product (DP)
Number of subjects: 48
Study 30230257 — intervention group
Group type: COMPARATOR
Intervention: Upper arm injection site
Number of subjects: 48
Study 30230257 — intervention group
Group type: COMPARATOR
Intervention: Thigh injection site
Number of subjects: 48
Study 30230257 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of emicizumab
Number of subjects: 48
Study 29073803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 71
Study 29073803 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 71
Study 29073803 — intervention group
Group type: EXPERIMENTAL
Intervention: Arteriograph
Number of subjects: 71
Study 29073803 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 71
Study 27228052 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux‐en‐Y gastric bypass (RYGB)
Number of subjects: 16
Study 27228052 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention
Number of subjects: 16
Study 27228052 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study 25004335 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg oral estradiol per day
Number of subjects: 256
Study 25004335 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg venlafaxine per day
Number of subjects: 256
Study 25004335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 22918526 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 28
Study 22918526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 19826112 — intervention group
Group type: EXPERIMENTAL
Intervention: 31 oncology drugs approved without a randomized trial
Number of subjects: 79
Study 19826112 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib (EGFR inhibitor)
Number of subjects: 79
Study 19826112 — intervention group
Group type: EXPERIMENTAL
Intervention: 31 oncology drugs
Number of subjects: 79
Study 19826112 — intervention group
Group type: EXPERIMENTAL
Intervention: 19 of the 31 drugs
Number of subjects: 79
Study 17207470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of calories, carbohydrates, and fat
Number of subjects: 62
Study 17207470 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported frequency of GI abnormalities
Number of subjects: 62
Study 17207470 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of dietary intake with stool consistency
Number of subjects: 62
Study 16120482 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Valproate
Number of subjects: 120
Study 16120482 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 120
Study 12690666 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous dopaminergic stimulation
Number of subjects: 0
Study 12690666 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile dopaminergic stimulation
Number of subjects: 0
Study 12690666 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopaminergic agonists
Number of subjects: 0
Study 12690666 — intervention group
Group type: EXPERIMENTAL
Intervention: Catechol‐O‐methyl transferase inhibitors
Number of subjects: 0
Study 9522658 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) 1 g/kg
Number of subjects: 43
Study 9522658 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MPPT) 30 mg/kg
Number of subjects: 43
Study 7652970 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 230
Study 7652970 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 2570086 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol decanoate (1.5 cc or 75 mg)
Number of subjects: 72
Study 2570086 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine decanoate (1 cc or 25 mg)
Number of subjects: 72
Study 2570086 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol decanoate
Number of subjects: 72
Study 2570086 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine decanoate
Number of subjects: 72
Study 183591 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of prednisone on alternate days
Number of subjects: 13
Study 183591 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets on alternate days
Number of subjects: 13
Study 183591 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone maintenance dosage after 2 years
Number of subjects: 13
Study 31116017 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based cognitive behavioral therapy
Number of subjects: 51
Study 31116017 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-based cognitive behavioral therapy
Number of subjects: 51
Study 31116017 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control condition
Number of subjects: 51
Study 29901860 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/14.4/10 μg
Number of subjects: 72
Study 29901860 — intervention group
Group type: EXPERIMENTAL
Intervention: BFF MDI 320/10 μg
Number of subjects: 72
Study 29901860 — intervention group
Group type: COMPARATOR
Intervention: BUD/FORM DPI 320/9-μg delivered dose
Number of subjects: 72
Study 28598402 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinsing (CHO: 1.6 g/25 mL)
Number of subjects: 24
Study 28598402 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine mouth rinsing (CAF: 67 mg/25 mL)
Number of subjects: 24
Study 28598402 — intervention group
Group type: EXPERIMENTAL
Intervention: Guarana mouth rinsing (GUA: 0.4 g/25 mL)
Number of subjects: 24
Study 28598402 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinsing (PL)
Number of subjects: 24
Study 25740807 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-diameter deep anterior lamellar keratoplasty (L-DALK)
Number of subjects: 132
Study 25740807 — intervention group
Group type: COMPARATOR
Intervention: Standard deep anterior lamellar keratoplasty (S-DALK)
Number of subjects: 132
Study 23620934 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint Massage (AM)
Number of subjects: 120
Study 23620934 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 120
Study 23620934 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 120
Study 21339436 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted decision support during trauma resuscitation
Number of subjects: 1171
Study 21339436 — intervention group
Group type: COMPARATOR
Intervention: Baseline control group
Number of subjects: 1171
Study 18076229 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 minutes of lower-limb massage (M)
Number of subjects: 37
Study 18076229 — intervention group
Group type: COMPARATOR
Intervention: 15 minutes of placebo ultrasound (PU)
Number of subjects: 37
Study 18076229 — intervention group
Group type: COMPARATOR
Intervention: Rest (R)
Number of subjects: 37
Study 15856721 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 195
Study 15856721 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 195
Study 12221214 — intervention group
Group type: EXPERIMENTAL
Intervention: Prowashonupana (PW) barley
Number of subjects: 10
Study 12221214 — intervention group
Group type: COMPARATOR
Intervention: Standard barley (BZ) 594.35.e
Number of subjects: 10
Study 10223231 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU 2600 mg/m2 with LV 100 mg/m2 administered via a portable infusion pump over 24 hours once a week for 5 weeks
Number of subjects: 36
Study 8552441 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEpo
Number of subjects: 28
Study 8552441 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study 2695558 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser trabeculoplasty (ALT)
Number of subjects: 35
Study 2695558 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (vascular medications)
Number of subjects: 35
Study 343787 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincamine containing formulation (Pervincamin forte retard or Pervincamin ampoules)
Number of subjects: 0
Study 343787 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31504690 — intervention group
Group type: EXPERIMENTAL
Intervention: High water intake (2.5 L/d)
Number of subjects: 75
Study 31504690 — intervention group
Group type: EXPERIMENTAL
Intervention: Low water intake (0.5 L/d)
Number of subjects: 75
Study 31504690 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum (AL) water intake
Number of subjects: 75
Study 28627913 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional retraining (AR)
Number of subjects: 64
Study 28627913 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 64
Study 25710953 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 53
Study 25710953 — intervention group
Group type: COMPARATOR
Intervention: Fuji IX GIC
Number of subjects: 53
Study 25710953 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCT
Number of subjects: 53
Study 25710953 — intervention group
Group type: COMPARATOR
Intervention: PA radiographs
Number of subjects: 53
Study 23449367 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 1335
Study 21256094 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole administered as a liniment
Number of subjects: 0
Study 19483180 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR 300 mg/day
Number of subjects: 195
Study 19483180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 19483180 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 195
Study 16392147 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,450-nm diode laser treatment with cryogen cooling spray, 4, 8, or 12 J/cm2, 3 treatments at 6-week intervals
Number of subjects: 11
Study 16392147 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated side of the body)
Number of subjects: 11
Study 15646404 — intervention group
Group type: EXPERIMENTAL
Intervention: IVCD estimation by echocardiographic method (study group)
Number of subjects: 100
Study 15646404 — intervention group
Group type: COMPARATOR
Intervention: Traditional method for dry weight adjustment (control group)
Number of subjects: 100
Study 12685794 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical transmucosal implants (Nobel Biocare AB), 3.75 mm large and at least 9 mm long, immediately loaded with an implant‐retained overdenture.
Number of subjects: 10
Study 12685794 — intervention group
Group type: COMPARATOR
Intervention: Standard Brånemark implants (MK II; Nobel Biocare AB), 3.75 mm large and at least 10 mm long, immediately loaded with an implant‐retained overdenture.
Number of subjects: 10
Study 9859076 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime (400 mg/24 h in a single daily dose for 12 days)
Number of subjects: 126
Study 9859076 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (1 g/8 h per os) plus netilmicin (4 mg/kg/24 h in a single intramuscular daily dose for 5 days)
Number of subjects: 126
Study 9859076 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 126
Study 9859076 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin plus netilmicin
Number of subjects: 126
Study 9859076 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime and Amoxicillin plus netilmicin
Number of subjects: 126
Study 7631301 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemovasal (glycosaminoglycan) administered in 3 different i.m. doses as single injections
Number of subjects: 36
Study 7631301 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemovasal (300 mg daily oral dose for one week)
Number of subjects: 36
Study 7631301 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 36
Study 7631301 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 36
Study 1974070 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg alpidem
Number of subjects: 24
Study 1974070 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg alpidem
Number of subjects: 24
Study 1974070 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg lorazepam
Number of subjects: 24
Study 1974070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 752851 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine, cyclophosphamide, methotrexate, and 5-fluorouracil after conventional curative treatment
Number of subjects: 0
Study 752851 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31968279 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based evaluation of executive function (Home-MET)
Number of subjects: 160
Study 31125767 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP followed by 1x immediate application of aPDT and 2x subsequent applications of aPDT without SRP
Number of subjects: 40
Study 31125767 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 40
Study 28518132 — intervention group
Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy (VL)
Number of subjects: 100
Study 28518132 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 100
Study 28518132 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL) after crossover to VL
Number of subjects: 100
Study 28518132 — intervention group
Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy (VL) after crossover from DL
Number of subjects: 100
Study 28518132 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL) before crossover to VL
Number of subjects: 100
Study 25924679 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD stages 1-3B (without diabetes or vascular disease)
Number of subjects: 7246
Study 25924679 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD stage 5 (not on dialysis)
Number of subjects: 7246
Study 25924679 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance dialysis
Number of subjects: 7246
Study 25924679 — intervention group
Group type: EXPERIMENTAL
Intervention: Functioning kidney transplant
Number of subjects: 7246
Study 25924679 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fatal major vascular events (for patients on dialysis)
Number of subjects: 7246
Study 25924679 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fatal major vascular events (for patients not on dialysis)
Number of subjects: 7246
Study 24018896 — intervention group
Group type: COMPARATOR
Intervention: CAB algorithm
Number of subjects: 108
Study 24018896 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC algorithm
Number of subjects: 108
Study 21336855 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (intraperitoneal cisplatin, postoperative intravenous cisplatin, 5-fluorouracil, and daily oral FU (UFT) for 12 months)
Number of subjects: 268
Study 21336855 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 268
Study 18471914 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy radiotherapy
Number of subjects: 1000
Study 17384492 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonography for diagnosis and postoperative follow-up
Number of subjects: 26
Study 17384492 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonography
Number of subjects: 26
Study 17384492 — intervention group
Group type: COMPARATOR
Intervention: Nerve conduction studies
Number of subjects: 26